Abstract
We audited the accuracy of the Systemic Anti-Cancer Therapy dataset as a resource for rapid analysis of outcomes for patients, in this example, receiving Cancer Drug Fund funded monoclonal antibodies to treat metastatic colorectal cancer. We concluded that the Systemic Anti-Cancer Therapy dataset is a potentially valuable resource for rapidly determining survival outcome for patients treated with chemotherapy.
Original language | English |
---|---|
Pages (from-to) | e134-e136 |
Journal | Clinical Oncology |
Volume | 29 |
Issue number | 7 |
DOIs | |
Publication status | Published - Jul 2017 |
Bibliographical note
Publisher Copyright:© 2017
Keywords
- CDF
- Cancer Drug Fund
- SACT
- Systemic Anti-Cancer Therapy dataset
- cetuximab
- colorectal